Cart
sales@molnova.com
SAR348830
CAS No. 1462949-64-9
SAR348830( —— )
Catalog No. M20540 CAS No. 1462949-64-9
SAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 5MG | 39 | In Stock |
|
| 10MG | 56 | In Stock |
|
| 25MG | 92 | In Stock |
|
| 50MG | 150 | In Stock |
|
| 100MG | 228 | In Stock |
|
| 200MG | 343 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSAR348830
-
NoteResearch use only, not for human use.
-
Brief DescriptionSAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
-
DescriptionSAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1462949-64-9
-
Formula Weight537.7
-
Molecular FormulaC28H32FN5O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (185.99 mM)
-
SMILESCOc1ccc(F)cc1-c1c(CO)sc2cnc(Nc3ccc(cc3OC(C)C)N3CCN(C)CC3)nc12
-
Chemical Name7-(5-Fluoro-2-methoxyphenyl)-2-[[2-(1-methylethoxy)-4-(4-methyl-1-piperazinyl)phenyl]amino]-thieno[32-d]pyrimidine-6-methanol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
UCM-1336
UCM-1336 is a potent ICMT inhibitor with an IC50 of 2 μM which is selective against the other enzymes involved in the post-translational modifications of Ras.
-
20-Hydroxylucidenic ...
20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.
-
Brivaracetam (alfaR,...
Brivaracetam (alfaR, 4S)-Isomer
